In a prior investigation on breast cancer, it was observed that individuals who exhibited elevated levels of CD8+ T lymphocytes near the invasive margins (IMs) of tumors experienced an unfavorable prognosis after 14 years. The gene discussed is CD8A; the disease is breast carcinoma.